CAR T-Cell Therapy, Kidney Transplant, Highly Sensitized Patients, End-Stage Kidney Disease, Organ Transplantation, cPRA, Clinical Trial, Immunotherapy, Nephrology, Transplant Surgery, Antibody Reduction, Cell Therapy, Kidney Failure, Transplant Immunology, Penn Medicine, antibody reduction therapy, cellular immunotherapy, transplant surgery, kidney failure treatment, BCMA CAR T cells, CD19 CAR T cells, clinical trial kidney transplantation
CAR T-Cell Therapy Offers Hope for Highly Sensitized Patients

Key Summary Researchers at the University of Pennsylvania successfully used CAR T-cell therapy to reduce.